Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
about
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaArtemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malariaArtesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malariaDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaReduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemetherEfficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, SudanEfficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategiesArtemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in UgandaRandomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparumPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateA randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in PeruOpen-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malariaFocused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, CambodiaArtemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialTargeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceAssessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates.Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2.Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.Genetic diversity in merozoite surface protein-1 and 2 among Plasmodium falciparum isolates from malarious districts of tribal dominant state of Jharkhand, India.Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemicPlasmodium falciparum genotype diversity in artemisinin derivatives treatment failure patients along the Thai-Myanmar borderHigh prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese childrenAssessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.Genetic diversity of Plasmodium vivax malaria in China and Myanmar.Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindnessArtemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up studyValidation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trialsPlacental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting.History, dynamics, and public health importance of malaria parasite resistance.Genetic diversity of Plasmodium falciparum isolates from Pahang, Malaysia based on MSP-1 and MSP-2 genes.Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar.
P2860
Q21143739-7A5B3779-BD84-4546-9D2B-48E404278DA6Q24188020-16FE0F60-54A4-4566-B285-1BAAAA211CAFQ24198103-895DA965-DA6C-4605-9F46-67158DE7887DQ24201077-D16939BD-CC09-4CD5-90DE-CBE2E8AECB8CQ24792020-C4AD881C-7045-4AA6-A172-F72DD9AA5A19Q24801453-3557D71E-3ADC-4A57-A0D3-B13B07568CC5Q24812384-882AEF22-AADB-4435-AD3B-AB49A178260AQ24815752-DA846D1E-5BF6-41CC-A849-0B0D3DE5877AQ28469026-0ECF6232-ABE0-48F3-A85A-A87E6CFFE469Q28469316-B0DCB147-8E9C-4670-ADC0-2DEA7BF88973Q28469333-D8BDC1BD-84BE-4E49-AB9C-DDA1B5FC5169Q28472247-089610E4-F1C1-42C0-AD13-130FF0A3EFCDQ28484164-A2C79B74-BD2D-4CD0-8433-2317061BB827Q28542921-C2923DDD-3BFD-4973-9787-532CBBE59AAEQ28546636-11B36687-E0DE-4BB5-AD9F-265AB1C4EC06Q31151729-05B1491C-F66E-4565-BF79-EB2351DD6E5BQ33251914-559ADD91-3552-4984-9F9F-2D042C1BA19BQ33319559-0B154F93-2414-47CF-8C1F-E6FB2ED1FE80Q33515574-789F481C-B148-480B-A5B9-13BD506183EEQ33590165-9FB9D192-DFF3-4605-87E9-67D1423A870FQ33702580-6ED4DEEA-7E77-4176-9ED4-22429DB6AA00Q33763957-D8216840-2AB0-4246-8203-00FB9C5F7014Q33873650-A6119042-256C-4EE8-BF27-74B649F05184Q33918567-328B92E9-440A-418B-BD5E-975CF9C24917Q34221869-8627D8CC-625A-4144-BF23-F431B26D33B1Q34388722-AA65CAB3-5060-40A4-B138-9198FF35C724Q34648820-1023DEBB-09BA-4AE9-BACB-877D630CDEC3Q34775174-4E720E2A-C0B5-4FC5-89D4-02328631881AQ35038632-7F3E48BD-B54A-427B-866D-B79974949982Q35046457-E1D0D31E-C5C4-43A8-80B0-23D9FBFD5DD3Q35126436-B989B70A-5BF9-4AD6-B01E-2D1CE64B0808Q35207455-1F5644B9-7ECB-45E6-877E-A18F7D8F9E77Q35218484-EBE523C6-AD7B-4575-904A-28CB29CCE940Q35219959-7EBDEFCC-84F4-4823-8ECE-D8F551CC59C8Q35250823-0D61EC3C-F01D-492D-B313-1CC2E283B0E2Q35283214-B927F310-2581-485C-AC5F-0FE8560C7D28Q35505497-81E988D9-9E6A-4770-8940-B00E7FF26024Q35545447-EB38FA5B-CA90-48EF-BAB5-79D7D0A9AAB6Q35690078-9519EC66-3040-482C-84CA-7E671E368665Q35716419-792545A8-DCF5-4597-BAD4-BA791482D225
P2860
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Distinguishing recrudescence f ...... ng of msp-1, msp-2, and glurp.
@en
type
label
Distinguishing recrudescence f ...... ng of msp-1, msp-2, and glurp.
@en
prefLabel
Distinguishing recrudescence f ...... ng of msp-1, msp-2, and glurp.
@en
P2093
P1476
Distinguishing recrudescence f ...... ing of msp-1, msp-2, and glurp
@en
P2093
Adithya Cattamanchi
Alan Hubbard
Daniel Kyabayinze
Grant Dorsey
Philip J Rosenthal
P304
P407
P577
2003-02-01T00:00:00Z